Evidence map›Paper›PMID 41430617›Full record

ArticleBioData mining2025

An unsupervised tool for biomarker discovery and cancer subtyping applied to glioblastoma.

Roberta Coletti, J Orestes Cerdeira, Marcos Raydan, Marta B Lopes

Abstract read
In one paragraph

Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roberta ColettiCenter for Mathematics and Applications (NOVA Math), NOVA School of Science and Technology (NOVA FCT), Universidade NOVA de Lisboa, Campus da Caparica, Caparica, 2829-516, Portugal. roberta.coletti.91@gmail.com.
J Orestes CerdeiraCenter for Mathematics and Applications (NOVA Math), NOVA School of Science and Technology (NOVA FCT), Universidade NOVA de Lisboa, Campus da Caparica, Caparica, 2829-516, Portugal.
Marcos RaydanCenter for Mathematics and Applications (NOVA Math), NOVA School of Science and Technology (NOVA FCT), Universidade NOVA de Lisboa, Campus da Caparica, Caparica, 2829-516, Portugal.
Marta B LopesCenter for Mathematics and Applications (NOVA Math), NOVA School of Science and Technology (NOVA FCT), Universidade NOVA de Lisboa, Campus da Caparica, Caparica, 2829-516, Portugal. marta.lopes@fct.unl.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-dimensional omics data often contain more variables than observations, which can lead to overfitting and negatively impact the results of classical data analysis methods. To address the issue, supervised variable selection methods are often used, incorporating penalty terms into the model. While effective for selecting task-specific variables, this approach may not preserve the overall dataset structure for multiple downstream analyses. This study aims to evaluate unsupervised variable selection approaches and introduce a novel tool that improves data interpretability while maintaining biological information.

resultsWe assessed multiple unsupervised variable selection techniques to identify a representative subset of the original dataset. Based on this evaluation, we developed TRIM-IT, a computational tool that integrates unsupervised variable selection, clustering, survival analysis, and differential gene expression analysis. TRIM-IT was applied to glioblastoma transcriptomics data, uncovering three distinct patient clusters. These clusters correlated with tumor histology, exhibited significantly different survival outcomes, and revealed molecular profiles that suggest potential biomarker candidates.

conclusionTRIM-IT provides a novel approach for analyzing high-dimensional omics data while preserving key biological insights. Its ability to identify meaningful patient subgroups and molecular signatures highlights its applicability across various biomedical research contexts. The tool is implemented in R and the code is publicly available for reproduction and adaptation to other studies.

Indexed as

ClusteringCombinatorial optimizationGlioblastomaGliomaMOMIPTRIM-ITUnsupervised variable selection

Identifiers

PMID41430617
PMCPMC12720448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.